Home
>
National Drug Code (NDC)
>
Persantine
Persantine - 0597-0019-01 - (dipyridamole)
Drug Information of Persantine
| Product NDC: | 0597-0019 |
| Proprietary Name: | Persantine |
| Non Proprietary Name: | dipyridamole |
| Active Ingredient(s): | 75 mg/1 & nbsp; dipyridamole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Persantine
| Product NDC: | 0597-0019 |
| Labeler Name: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012836 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990601 |
Package Information of Persantine
| Package NDC: | 0597-0019-01 |
| Package Description: | 100 TABLET, COATED in 1 BOTTLE (0597-0019-01) |
NDC Information of Persantine
| NDC Code | 0597-0019-01 |
| Proprietary Name | Persantine |
| Package Description | 100 TABLET, COATED in 1 BOTTLE (0597-0019-01) |
| Product NDC | 0597-0019 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dipyridamole |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 19990601 |
| Marketing Category Name | NDA |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | DIPYRIDAMOLE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
